# OnCo record exelixis (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/exelixis/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "exelixis" ;
  schema:name "Exelixis"@en ;
  schema:description "Exelixis makes cabozantinib (Cabometyx), used in kidney, liver, thyroid and, since 2025, neuroendocrine cancers."@en ;
  schema:url <https://onco.cc/companies/exelixis/>, <https://www.exelixis.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Exelixis> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5419989> ;
  schema:citation <https://www.exelixis.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/thyroid/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/cabozantinib/>, <https://onco.cc/drugs/zanzalintinib/> ;
  onco:trials <https://onco.cc/trials/nct03755791/>, <https://onco.cc/trials/nct05425940/>, <https://onco.cc/trials/nct04446117/>, <https://onco.cc/trials/nct03690388/>, <https://onco.cc/trials/nct03899155/> .